Sphera Global Healthcare Fund
Asia, Tel Aviv, Israel, Tel Aviv
Description
Sphera Global Healthcare Fund is a long/short equity fund that is focused on the global pharmaceutical and biotech industries.
Investor Profile
Sphera Global Healthcare Fund has made 27 investments, with 4 in the past 12 months and 4% as lead.
Stage Focus
- Post Ipo Equity (67%)
- Series B (15%)
- Series E (7%)
- Series C (4%)
- Series Unknown (4%)
- Series A (4%)
Country Focus
- United States (52%)
- Canada (22%)
- Sweden (7%)
- China (7%)
'/%3e%3cuse xlink:href='%23a' transform='rotate(23.036 .093 25.536)'/%3e%3cuse xlink:href='%23a' transform='rotate(45.87 1.273 16.18)'/%3e%3cuse xlink:href='%23a' transform='rotate(69.945 .996 12.078)'/%3e%3cuse xlink:href='%23a' transform='rotate(20.66 -19.689 31.932)'/%3e%3c/svg%3e)
- Switzerland (4%)
- United Kingdom (4%)
'%3e%3cpath fill='%23012169' d='M0 0v30h60V0z'/%3e%3cpath stroke='%23fff' stroke-width='6' d='m0 0 60 30m0-30L0 30'/%3e%3cpath stroke='%23C8102E' stroke-width='4' d='m0 0 60 30m0-30L0 30' clip-path='url(%23b)'/%3e%3cpath stroke='%23fff' stroke-width='10' d='M30 0v30M0 15h60'/%3e%3cpath stroke='%23C8102E' stroke-width='6' d='M30 0v30M0 15h60'/%3e%3c/g%3e%3c/svg%3e)
- Israel (4%)
Industry Focus
- Biotechnology
- Pharmaceutical
- Health Care
- Therapeutics
- Medical
- Biopharma
- Life Science
- Health Diagnostics
- Neuroscience
- Genetics
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.
'/%3e%3cuse xlink:href='%23a' transform='rotate(144 450 300)'/%3e%3cuse xlink:href='%23a' transform='rotate(216 450 300)'/%3e%3cuse xlink:href='%23a' transform='rotate(288 450 300)'/%3e%3c/svg%3e)
